eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | acromegaly |
| Comorbidity | C0206754|neuroendocrine tumors |
| Sentences | 2 |
| PubMedID- 24119925 | In less than 2% of the cases, acromegaly results from ghrh-secreting neuroendocrine tumors usually located in the lungs, thymus and endocrine pancreas [1,2]. |
| PubMedID- 25834454 | To avoid this issue, octreotide long-acting release (lar) and lanreotide autogel are now available, both of which can be administered monthly in cases of acromegaly or patients with neuroendocrine tumors.35,49 this is available also for pasireotide, and the lar formulation is expected to produce fewer peak-to-trough fluctuations than the subcutaneous formulation, which could reduce the drug’s adverse effects, such as nausea and hyperglycemia. |
Page: 1